MORGAN STANLEY PLC/CALL/STRYKER CORP./500/0.1/19.12.25 Stock

Warrant

DE000MG0YH34

Market Closed - Bid/Ask 02:48:41 2024-05-23 pm EDT Pre-market 02:02:36 am
0.73 EUR +2.82% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./500/0.1/19.12.25 0.745 +2.05%
1 month-15.12%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-23 0.73 +2.82%
24-05-22 0.71 +9.23%
24-05-21 0.65 -1.52%
24-05-20 0.66 -4.35%
24-05-17 0.69 -5.48%

Delayed Quote Börse Stuttgart

Last update May 23, 2024 at 02:48 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN MG0YH3
ISINDE000MG0YH34
Date issued 2024-03-27
Strike 500 $
Maturity 2025-12-19 (575 Days)
Parity 10 : 1
Emission price 0.94
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.45
Lowest since issue 0.65
Spread 0.05
Spread %6.49%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.1 USD
Average target price
372.4 USD
Spread / Average Target
+12.79%
Consensus